![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MRPS12 |
Gene summary for MRPS12 |
![]() |
Gene information | Species | Human | Gene symbol | MRPS12 | Gene ID | 6183 |
Gene name | mitochondrial ribosomal protein S12 | |
Gene Alias | MPR-S12 | |
Cytomap | 19q13.2 | |
Gene Type | protein-coding | GO ID | GO:0006412 | UniProtAcc | A0A024R0H2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6183 | MRPS12 | GSM4909281 | Human | Breast | IDC | 1.14e-06 | 3.23e-01 | 0.21 |
6183 | MRPS12 | GSM4909282 | Human | Breast | IDC | 1.36e-12 | 3.85e-01 | -0.0288 |
6183 | MRPS12 | GSM4909285 | Human | Breast | IDC | 1.35e-23 | 5.63e-01 | 0.21 |
6183 | MRPS12 | GSM4909290 | Human | Breast | IDC | 2.55e-03 | 3.61e-01 | 0.2096 |
6183 | MRPS12 | GSM4909291 | Human | Breast | IDC | 5.00e-09 | 5.43e-01 | 0.1753 |
6183 | MRPS12 | GSM4909296 | Human | Breast | IDC | 2.10e-03 | 1.66e-01 | 0.1524 |
6183 | MRPS12 | GSM4909298 | Human | Breast | IDC | 2.00e-06 | 2.52e-01 | 0.1551 |
6183 | MRPS12 | GSM4909304 | Human | Breast | IDC | 4.66e-03 | 2.44e-01 | 0.1636 |
6183 | MRPS12 | GSM4909306 | Human | Breast | IDC | 2.41e-04 | 2.93e-01 | 0.1564 |
6183 | MRPS12 | GSM4909307 | Human | Breast | IDC | 3.29e-02 | 2.81e-01 | 0.1569 |
6183 | MRPS12 | GSM4909308 | Human | Breast | IDC | 3.09e-02 | 2.86e-01 | 0.158 |
6183 | MRPS12 | GSM4909311 | Human | Breast | IDC | 2.27e-14 | -1.29e-01 | 0.1534 |
6183 | MRPS12 | GSM4909312 | Human | Breast | IDC | 5.60e-06 | 6.39e-02 | 0.1552 |
6183 | MRPS12 | GSM4909317 | Human | Breast | IDC | 1.08e-02 | 3.09e-01 | 0.1355 |
6183 | MRPS12 | GSM4909319 | Human | Breast | IDC | 1.85e-15 | -5.53e-02 | 0.1563 |
6183 | MRPS12 | GSM4909321 | Human | Breast | IDC | 1.34e-04 | 1.72e-01 | 0.1559 |
6183 | MRPS12 | brca1 | Human | Breast | Precancer | 1.60e-12 | 4.20e-01 | -0.0338 |
6183 | MRPS12 | brca2 | Human | Breast | Precancer | 1.57e-05 | 2.48e-01 | -0.024 |
6183 | MRPS12 | brca3 | Human | Breast | Precancer | 5.56e-03 | 1.70e-01 | -0.0263 |
6183 | MRPS12 | brca10 | Human | Breast | Precancer | 6.47e-03 | -2.10e-01 | -0.0029 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00325432 | Breast | IDC | mitochondrial translation | 13/1434 | 76/18723 | 4.81e-03 | 3.67e-02 | 13 |
GO:003254311 | Breast | DCIS | mitochondrial translation | 13/1390 | 76/18723 | 3.70e-03 | 2.99e-02 | 13 |
GO:014005313 | Esophagus | ESCC | mitochondrial gene expression | 93/8552 | 108/18723 | 1.96e-18 | 2.03e-16 | 93 |
GO:003254314 | Esophagus | ESCC | mitochondrial translation | 68/8552 | 76/18723 | 1.02e-15 | 6.86e-14 | 68 |
GO:0032543 | Liver | Cirrhotic | mitochondrial translation | 40/4634 | 76/18723 | 1.61e-07 | 4.29e-06 | 40 |
GO:0140053 | Liver | Cirrhotic | mitochondrial gene expression | 49/4634 | 108/18723 | 2.35e-06 | 4.31e-05 | 49 |
GO:01400531 | Liver | HCC | mitochondrial gene expression | 82/7958 | 108/18723 | 1.49e-12 | 7.20e-11 | 82 |
GO:00325431 | Liver | HCC | mitochondrial translation | 62/7958 | 76/18723 | 2.95e-12 | 1.34e-10 | 62 |
GO:01400533 | Oral cavity | OSCC | mitochondrial gene expression | 78/7305 | 108/18723 | 2.37e-12 | 9.86e-11 | 78 |
GO:00325434 | Oral cavity | OSCC | mitochondrial translation | 59/7305 | 76/18723 | 7.21e-12 | 2.70e-10 | 59 |
GO:003254313 | Oral cavity | LP | mitochondrial translation | 43/4623 | 76/18723 | 2.85e-09 | 1.26e-07 | 43 |
GO:014005312 | Oral cavity | LP | mitochondrial gene expression | 53/4623 | 108/18723 | 3.54e-08 | 1.27e-06 | 53 |
GO:00325433 | Prostate | BPH | mitochondrial translation | 23/3107 | 76/18723 | 2.21e-03 | 1.22e-02 | 23 |
GO:01400532 | Prostate | BPH | mitochondrial gene expression | 29/3107 | 108/18723 | 4.68e-03 | 2.25e-02 | 29 |
GO:003254312 | Prostate | Tumor | mitochondrial translation | 24/3246 | 76/18723 | 1.73e-03 | 1.03e-02 | 24 |
GO:014005311 | Prostate | Tumor | mitochondrial gene expression | 31/3246 | 108/18723 | 2.31e-03 | 1.30e-02 | 31 |
GO:00325436 | Skin | cSCC | mitochondrial translation | 47/4864 | 76/18723 | 4.70e-11 | 2.22e-09 | 47 |
GO:01400535 | Skin | cSCC | mitochondrial gene expression | 56/4864 | 108/18723 | 8.06e-09 | 2.56e-07 | 56 |
GO:01400536 | Thyroid | PTC | mitochondrial gene expression | 51/5968 | 108/18723 | 6.04e-04 | 3.83e-03 | 51 |
GO:00325437 | Thyroid | PTC | mitochondrial translation | 38/5968 | 76/18723 | 7.52e-04 | 4.67e-03 | 38 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0301018 | Breast | Precancer | Ribosome | 80/684 | 167/8465 | 7.33e-44 | 2.32e-41 | 1.77e-41 | 80 |
hsa0301019 | Breast | Precancer | Ribosome | 80/684 | 167/8465 | 7.33e-44 | 2.32e-41 | 1.77e-41 | 80 |
hsa0301024 | Breast | IDC | Ribosome | 83/867 | 167/8465 | 6.07e-39 | 9.87e-37 | 7.38e-37 | 83 |
hsa0301034 | Breast | IDC | Ribosome | 83/867 | 167/8465 | 6.07e-39 | 9.87e-37 | 7.38e-37 | 83 |
hsa0301044 | Breast | DCIS | Ribosome | 82/846 | 167/8465 | 8.69e-39 | 1.40e-36 | 1.03e-36 | 82 |
hsa0301054 | Breast | DCIS | Ribosome | 82/846 | 167/8465 | 8.69e-39 | 1.40e-36 | 1.03e-36 | 82 |
hsa03010 | Colorectum | AD | Ribosome | 96/2092 | 167/8465 | 8.28e-20 | 5.54e-18 | 3.54e-18 | 96 |
hsa030101 | Colorectum | AD | Ribosome | 96/2092 | 167/8465 | 8.28e-20 | 5.54e-18 | 3.54e-18 | 96 |
hsa030102 | Colorectum | SER | Ribosome | 92/1580 | 167/8465 | 2.21e-26 | 3.66e-24 | 2.66e-24 | 92 |
hsa030103 | Colorectum | SER | Ribosome | 92/1580 | 167/8465 | 2.21e-26 | 3.66e-24 | 2.66e-24 | 92 |
hsa030104 | Colorectum | MSS | Ribosome | 96/1875 | 167/8465 | 1.82e-23 | 2.03e-21 | 1.24e-21 | 96 |
hsa030105 | Colorectum | MSS | Ribosome | 96/1875 | 167/8465 | 1.82e-23 | 2.03e-21 | 1.24e-21 | 96 |
hsa030106 | Colorectum | MSI-H | Ribosome | 87/797 | 167/8465 | 5.55e-46 | 1.80e-43 | 1.51e-43 | 87 |
hsa030107 | Colorectum | MSI-H | Ribosome | 87/797 | 167/8465 | 5.55e-46 | 1.80e-43 | 1.51e-43 | 87 |
hsa03010211 | Esophagus | ESCC | Ribosome | 129/4205 | 167/8465 | 1.43e-13 | 3.43e-12 | 1.75e-12 | 129 |
hsa03010310 | Esophagus | ESCC | Ribosome | 129/4205 | 167/8465 | 1.43e-13 | 3.43e-12 | 1.75e-12 | 129 |
hsa0301022 | Liver | Cirrhotic | Ribosome | 127/2530 | 167/8465 | 2.12e-35 | 7.06e-33 | 4.35e-33 | 127 |
hsa0301032 | Liver | Cirrhotic | Ribosome | 127/2530 | 167/8465 | 2.12e-35 | 7.06e-33 | 4.35e-33 | 127 |
hsa0301042 | Liver | HCC | Ribosome | 128/4020 | 167/8465 | 7.32e-15 | 2.23e-13 | 1.24e-13 | 128 |
hsa0301052 | Liver | HCC | Ribosome | 128/4020 | 167/8465 | 7.32e-15 | 2.23e-13 | 1.24e-13 | 128 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MRPS12 | SNV | Missense_Mutation | novel | c.268N>A | p.Glu90Lys | p.E90K | O15235 | protein_coding | deleterious(0.02) | probably_damaging(0.999) | TCGA-AR-A2LE-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | PD |
MRPS12 | SNV | Missense_Mutation | novel | c.16C>A | p.Leu6Ile | p.L6I | O15235 | protein_coding | deleterious(0.02) | benign(0.142) | TCGA-AR-A5QM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | anastrozole | PD |
MRPS12 | SNV | Missense_Mutation | novel | c.97C>G | p.Leu33Val | p.L33V | O15235 | protein_coding | tolerated(0.08) | possibly_damaging(0.611) | TCGA-UL-AAZ6-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | herceptin | SD |
MRPS12 | deletion | Frame_Shift_Del | novel | c.98delN | p.Leu33ArgfsTer26 | p.L33Rfs*26 | O15235 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
MRPS12 | SNV | Missense_Mutation | c.167C>T | p.Pro56Leu | p.P56L | O15235 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-A02K-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folinic | PD | |
MRPS12 | SNV | Missense_Mutation | rs768970230 | c.266N>A | p.Arg89His | p.R89H | O15235 | protein_coding | tolerated(0.33) | possibly_damaging(0.686) | TCGA-CM-6162-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
MRPS12 | SNV | Missense_Mutation | novel | c.43A>C | p.Thr15Pro | p.T15P | O15235 | protein_coding | tolerated(0.21) | benign(0.013) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MRPS12 | SNV | Missense_Mutation | rs766262829 | c.341N>A | p.Arg114His | p.R114H | O15235 | protein_coding | deleterious(0.01) | benign(0.071) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MRPS12 | SNV | Missense_Mutation | rs754668341 | c.361N>A | p.Val121Ile | p.V121I | O15235 | protein_coding | deleterious(0.04) | benign(0.225) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MRPS12 | SNV | Missense_Mutation | c.194N>T | p.Thr65Met | p.T65M | O15235 | protein_coding | deleterious(0.01) | probably_damaging(0.95) | TCGA-D1-A17B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |